469 related articles for article (PubMed ID: 23778906)
1. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.
Simmonds MC; Brown JV; Heirs MK; Higgins JP; Mannion RJ; Rodgers MA; Stewart LA
Ann Intern Med; 2013 Jun; 158(12):877-89. PubMed ID: 23778905
[TBL] [Abstract][Full Text] [Related]
3. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
Carragee EJ; Hurwitz EL; Weiner BK
Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796
[TBL] [Abstract][Full Text] [Related]
4. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials.
Chen Z; Ba G; Shen T; Fu Q
Arch Orthop Trauma Surg; 2012 Dec; 132(12):1725-40. PubMed ID: 22941273
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
Resnick D; Bozic KJ
Ann Intern Med; 2013 Jun; 158(12):912-3. PubMed ID: 23778909
[No Abstract] [Full Text] [Related]
7. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Proteins in Anterior Cervical Fusion: A Systematic Review and Meta-Analysis.
Zadegan SA; Abedi A; Jazayeri SB; Nasiri Bonaki H; Jazayeri SB; Vaccaro AR; Rahimi-Movaghar V
World Neurosurg; 2017 Aug; 104():752-787. PubMed ID: 28315798
[TBL] [Abstract][Full Text] [Related]
9. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
10. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the Impact of Patient Characteristics on Estimates of Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Lumbar Spinal Fusion.
Laurie AL; Chen Y; Chou R; Fu R
Spine (Phila Pa 1976); 2016 Sep; 41(18):E1115-E1123. PubMed ID: 27031772
[TBL] [Abstract][Full Text] [Related]
12. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
Kuntz RE
Ann Intern Med; 2013 Jun; 158(12):914-5. PubMed ID: 23778910
[No Abstract] [Full Text] [Related]
13. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
14. Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
Laine C; Guallar E; Mulrow C; Taichman DB; Cornell JE; Cotton D; Griswold ME; Localio AR; Meibohm AR; Stack CB; Williams SV; Goodman SN
Ann Intern Med; 2013 Jun; 158(12):916-8. PubMed ID: 23778911
[No Abstract] [Full Text] [Related]
15. A historic moment for open science: the Yale University Open Data Access project and medtronic.
Krumholz HM; Ross JS; Gross CP; Emanuel EJ; Hodshon B; Ritchie JD; Low JB; Lehman R
Ann Intern Med; 2013 Jun; 158(12):910-1. PubMed ID: 23778908
[No Abstract] [Full Text] [Related]
16. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
17. Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion.
Rodgers MA; Brown JV; Heirs MK; Higgins JP; Mannion RJ; Simmonds MC; Stewart LA
BMJ; 2013 Jun; 346():f3981. PubMed ID: 23788229
[TBL] [Abstract][Full Text] [Related]
18. Off-label innovation: characterization through a case study of rhBMP-2 for spinal fusion.
Schnurman Z; Smith ML; Kondziolka D
J Neurosurg Spine; 2016 Sep; 25(3):406-14. PubMed ID: 27104282
[TBL] [Abstract][Full Text] [Related]
19. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
20. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
Tannoury CA; An HS
Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
